And if I said the figure was nearer $55k what would you say?
Leaving the $’s aside the timeline stuff is interesting. DK has led us to expect revenues in the next few (3-4) months. Wouldn’t that suggest reimbursement approvals are well advanced or possibly known? I’ve had limited exposure to biotech/med stocks and generally exited prior to commercialisation. In your experience would a company typically announce when they have been added to the public health system purse?
Ann: Investor Update, page-35
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.867K | 573.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4186862 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 15328756 | 23 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |